FNY Partners Fund’s Medtronic MDT Stock Holding History

FNY Partners Fund’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-50	Closed	-$4K	–	910
2017 Q1	$4K	Buy	+50	New	+$3.91K	﹤0.01%	1219

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

FNY Partners Fund's MDT Position: Q4 2017 in Review

FNY Partners Fund sold out of Medtronic (MDT) in Q4 2017, closing a stake of 1,000 shares — an estimated $77K sold.

FNY Partners Fund first reported a position in MDT in Q4 2016 and held it in 4 quarters. The position peaked at $169K in Q1 2017. 1,409 funds tracked by Wall St. Rank hold MDT as of Q4 2017.

FNY Partners Fund reported no remaining Medtronic position as of Q4 2017 after selling out during the quarter.
FNY Partners Fund sold 1,000 Medtronic shares in Q4 2017, an estimated $77K.
FNY Partners Fund first reported a position in Medtronic in Q4 2016 and held it in 4 quarters.
FNY Partners Fund's Medtronic position peaked at $169K in Q1 2017.
1,409 funds tracked by Wall St. Rank held Medtronic as of Q4 2017.

Based on FNY Partners Fund's 13F filing for Q4 2017, filed 24 Jan 2018.